Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03699891 · ClinicalTrials.gov registry record
Evaluation of the Fortilink IBF System With TETRAfuse Technology
A clinical trial, sponsored by RTI Surgical.
- Completed
- Registry status
- 119
- Enrollment target
NCT03699891 is a clinical trial that has completed, run by RTI Surgical. The registered enrollment target is 119 participants.
The verdict
NCT03699891 has completed, sponsored by RTI Surgical.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
This is a multi-center, post-market, retrospective study to collect safety and performance data for patients implanted with the Fortilink IBF System.
Interventions
- DEVICE Fortilink IBF System with TETRAfuse Technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2018-11-06 |
| Est. Completion | 2019-01-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03699891
The ClinicalTrials.gov registry entry for NCT03699891 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI Surgical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fortilink IBF System with TETRAfuse Technology is the first listed.
NCT03699891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03699891 about?
NCT03699891 is a clinical study titled "Evaluation of the Fortilink IBF System With TETRAfuse Technology". This is a multi-center, post-market, retrospective study to collect safety and performance data for patients implanted with the Fortilink IBF System.
What is the current status of trial NCT03699891?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2018-11-06. Estimated completion is 2019-01-15.
What interventions are being tested in trial NCT03699891?
The interventions under investigation include: Fortilink IBF System with TETRAfuse Technology (DEVICE).
Who is sponsoring clinical trial NCT03699891?
This trial is sponsored by RTI Surgical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.